Home > News & Media > News
Communication starts here.
2019.09
TWi's ANDA for Testosterone Gel 1.62% Pump CIII has been approved by US FDA
2019.07
TWi's ANDA for Fenofibric Acid DR Capsules has been approved by US FDA
2019.05
TWi successfully launches generic Diltiazem HCl ER Capsules in TWi label
2019.03
TWi successfully launches generic Cyclobenzaprine HCL ER Capsules in TWi label
2019.01
TWi's ANDA for Dimethyl Fumarate DR Capsules has been tentatively approved by US FDA
2019.01
TWi successfully launches generic Labetalol HCl Tablets in TWi label
2018.12
TWi's ANDA for Metoprolol Succinate ER Tablets has been approved by US FDA
2018.11
TWi's ANDA for Oxcarbazepine ER Tablets has been tentatively approved by US FDA
2018.10
TWi successfully launches generic Bupropion HCl ER Tablets in TWi label
2018.09
TWi's ANDA for Diltiazem HCl ER Capsules has been approved by US FDA

 

Pages:1 - 2 - 3 - 4 - 5 - 6 - 7 - 8« Pre · Next »